Rubio Monocoat Limespot Remover

Hazard statements (CLP)

H315, H319

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

No additional information available

Hazard pictograms

GHS07

Signal word

Warning

Hazard statements

H315 - Causes skin irritation. H319 - Causes serious eye irritation.

Precautionary statements

P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P264 - Wash hands, forearms and face thoroughly after handling. P280 - Wear protective gloves, eye protection. P302+P352 - IF ON SKIN: Wash with plenty of soap and water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P501 - Dispose of contents/container in accordance with local regulations.

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH Acetic acid, 80% aqueous solution (64-19-7) regulation, in accordance with Annex XIII Substance(s) not meeting the vPvB criteria of REACH Acetic acid, 80% aqueous solution (64-19-7) regulation, in accordance with Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 2 H319 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available